| LC control no. | n 81059892 |
|---|---|
| Descriptive conventions | rda |
| Personal name heading | Brady, Roscoe O. |
| Variant(s) | Brady, Roscoe |
| Located | Bethesda (Md.) |
| Death date | 2016-06-13 |
| Place of death | Bethesda (Md.) |
| Field of activity | Biochemistry Physiology Neurology Genetic diseases and disorders--Treatment |
| Affiliation | National Institute of Neurological Disorders and Stroke (U.S.) |
| Profession or occupation | Medical scientists |
| Found in | Symposium on the Neurochemistry of Nucleotides and Amino Acids, Philadelphia, 1958. The nuerochemistry of nucleotides and amino acids, 1960. Data from National Audiovisual Center for Control and therapy of genetic disease [VR] 1980 (Roscoe Brady) LC database, July 20, 2016 (hdg.: Brady, Roscoe O.; usage: Roscoe O. Brady) Washington post WWW site, viewed July 20, 2016 (Roscoe O. Brady, 92, a clinical researcher who received the prestigious Lasker Award for discovering the biochemical basis of the rare genetic metabolic disorders Gaucher and Fabry diseases and who developed the first enzyme replacement treatments for them, died June 13 [2016] at his home in North Bethesda, Md.; Dr. Brady was born in Ambler, Pa., and joined the National Institutes of Health in the mid-1950s, eventually becoming chief of the developmental and metabolic neurology branch in the Institute of Neurological Disorders and Stroke; his work led to diagnostic, carrier detection and prenatal tests for those disorders and Niemann-Pick and Tay-Sachs diseases) |
| Associated language | eng |
 |  |  |
View this record in: MARCXML | LC Authorities & Vocabularies | VIAF (Virtual International Authority File)
